Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants.
about
Animal Models in Studying Cerebral Arteriovenous MalformationRegulation of blood vessel sproutingContext-specific interactions between Notch and ALK1 cannot explain ALK1-associated arteriovenous malformations.Mutations in NOTCH1 cause Adams-Oliver syndromeDeletion of Rbpj from postnatal endothelium leads to abnormal arteriovenous shunting in mice.ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.A Snail1/Notch1 signalling axis controls embryonic vascular development.Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac.Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels.Human brain arteriovenous malformations express lymphatic-associated genes.Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression.Notch signaling in developmental and tumor angiogenesis.Family Based Whole Exome Sequencing Reveals the Multifaceted Role of Notch Signaling in Congenital Heart DiseaseCombined deficiency of Notch1 and Notch3 causes pericyte dysfunction, models CADASIL, and results in arteriovenous malformations.Vascular Notch proteins and Notch signaling in the peri-implantation mouse uterus.Endoglin is required in Pax3-derived cells for embryonic blood vessel formation.Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling.Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice.BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development.Notch signaling in the vasculatureETS factors regulate Vegf-dependent arterial specification.Notch1 and 4 signaling responds to an increasing vascular wall shear stress in a rat model of arteriovenous malformations.Blocking Notch in endothelial cells prevents arteriovenous fistula failure despite CKD.Endothelial signaling and the molecular basis of arteriovenous malformation.Hemogenic endothelial cell specification requires c-Kit, Notch signaling, and p27-mediated cell-cycle control.Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.How blood vessel networks are made and measured.Molecular pathways of notch signaling in vascular smooth muscle cells.Signaling required for blood vessel maintenance: molecular basis and pathological manifestations.EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.Abnormal arterial-venous fusions and fate specification in mouse embryos lacking blood flow.BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.Flt-1 (vascular endothelial growth factor receptor-1) is essential for the vascular endothelial growth factor-Notch feedback loop during angiogenesis.Notch ligand Delta-like 1 promotes in vivo vasculogenesis in human cord blood-derived endothelial colony forming cells.Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.Dynamic maternal and fetal Notch activity and expression in placentation.ALK1 signaling in development and disease: new paradigms.Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
P2860
Q26824121-01DEFFCD-AFE8-4416-9D02-D482DD7CA439Q27006807-34119AB0-2538-4790-AD0D-C3EFD220F115Q27302123-0049FD8F-BA9A-41B5-974E-6A45AEAEC69CQ28246210-CBB8A2D6-C882-44CB-8BC3-4691B5D72CDBQ30592602-D14072AD-52A8-4BB5-B045-FF9C8EB32BAAQ33719706-EFF76D47-B102-400D-B1D7-4594DDFE3EE7Q33736954-1BD84F62-8F41-40A4-9997-53CA44E94E86Q33830153-9CD695E9-5BDB-4DFF-8352-9D50736C7ACCQ34752162-5BE1D9E0-6C70-4394-BF15-CA25557CAAA5Q34824758-57E1BF4B-5C9E-46DC-99D1-70D4B309279BQ35181476-53480673-973C-4070-98B3-8BE47FEA3552Q36137696-F9636FB1-4BC2-4778-9553-9A3EC9218CE1Q36167703-A9DF3A5D-86C2-49E2-A871-4A1E56A11DD4Q36275463-310F24A3-640B-4228-8756-52DE7A947E3EQ36337071-41724451-E733-45AD-90FB-3FAFD6ECF148Q36395997-B78F2028-B067-4CDA-9202-674DE4391900Q36548425-CA211644-6276-4B8F-BA03-E79C4AFC6ECFQ36619170-DE8F547F-F726-4D57-AD7B-2CD694815604Q36648644-29B993B4-C928-4B4E-AF32-42B0DDBBA7A7Q36861805-EBAB8149-6E37-420C-B1DF-05F49AB156E1Q37125672-1BEBF3E7-3C30-4B1A-A90E-78681F951D2BQ37561474-BBDED62E-E346-443C-B676-A666288611F6Q37670317-F8B736F0-76FB-4E8B-A65F-DB503424FD94Q37671796-25DD0BD0-0114-4354-AD72-A555D7F13E35Q37715126-D7A78406-0452-4539-8833-963BAF58236AQ37897171-6CBB96C3-BFF8-46E3-84D5-8A60E2433B93Q37945438-EBD8EFC3-059B-4070-99B2-FA6EA0369A9AQ38003146-8838DC8C-B01F-42FE-8289-3674E2578332Q39752032-9D52647A-F8F8-4D31-9FC4-82683D1C2A92Q41520269-88E9DAED-6A66-480D-A948-273062E6EC16Q41697025-8F995886-562C-486F-9CC7-4365F4CDB5F2Q41878326-3D85E110-EEE4-40C1-A46D-AD6E5B269342Q42409352-D166EA77-56AC-4D95-8E28-98763DDD5EF9Q42579270-9B2D0326-3377-4CBC-A5CE-7F0998772BF8Q44839040-28C540A6-7405-4D6C-BFB7-E10B6C995E8BQ47146134-D5E043CA-8642-4DC6-B8B1-2D11485EA02CQ47856805-5A345B9B-AE02-44A0-967D-5742D42EE2F9Q49826259-65B33BE7-437A-4ECE-B937-0162A54F6C8F
P2860
Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Notch1 activation in mice caus ...... by ephrinB2 and EphB4 mutants.
@ast
Notch1 activation in mice caus ...... by ephrinB2 and EphB4 mutants.
@en
type
label
Notch1 activation in mice caus ...... by ephrinB2 and EphB4 mutants.
@ast
Notch1 activation in mice caus ...... by ephrinB2 and EphB4 mutants.
@en
prefLabel
Notch1 activation in mice caus ...... by ephrinB2 and EphB4 mutants.
@ast
Notch1 activation in mice caus ...... by ephrinB2 and EphB4 mutants.
@en
P2093
P2860
P356
P1433
P1476
Notch1 activation in mice caus ...... by ephrinB2 and EphB4 mutants.
@en
P2093
Christa Starling
Luke T Krebs
Thomas Gridley
P2860
P304
P356
10.1002/DVG.20599
P577
2010-03-01T00:00:00Z